Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.
Press releases published on August 13, 2025
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
Topline results from the OV329 Phase 1 safety, tolerability and biomarker study remain on track for a readout in Q3 2025 $7.0 million royalty monetization agreement signed with Immedica Pharma AB for future ganaxolone royalties, delivering capital to the …
Fifth Annual PropTech Breakthrough Awards Program Releases List of 2025 Featured Winners
GlobeNewswire
·
August 13, 2025
LOS ANGELES, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PropTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes the world’s most innovative real estate technology companies and solutions, today announced the …
BioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D™ Fusion Imaging for Interventional Cardiology
GlobeNewswire
·
August 13, 2025
SUNNYVALE, Calif. and UTRECHT, Netherlands, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, and CART-Tech, B.V., a …
BeyondSpring Reports Second‑Quarter 2025 Financial Results and Provides Corporate Update: Accelerates Momentum with Promising Clinical Advances and Strategic Leadership Appointment
GlobeNewswire
·
August 13, 2025
ASCO 2025 presentation: First-in-class agent Plinabulin drives immune re-sensitization in NSCLC patients progressed to PD-1/L1 therapies Med (Cell Press) Publication with MD Anderson Collaboration highlights Plinabulin’s rapid dendritic cell activation in …
MicroCloud Hologram Inc. Expects Net Profit for the First Half of 2025 to Exceed $33 Million
GlobeNewswire
·
August 13, 2025
SHENZHEN, China, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, announced its preliminary financial results for the first half of 2025 . HOLO anticipates a significant …
Refold AI emerges from stealth with $6.5M to kill the enterprise “integration tax”
GlobeNewswire
·
August 13, 2025
San Mateo, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Enterprise software runs on APIs but connecting those APIs remains frustratingly manual. Every new workflow, system upgrade, or edge case spawns new tickets. Refold AI, a new startup rethinking integrations from …
Clinical Microbiology Market to Reach $6.9 Billion by 2029, Driven by Advanced Diagnostics and Regulatory Demand | MarketsandMarkets™.
GlobeNewswire
·
August 13, 2025
Delray Beach, FL, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Stringent quality standards, technological innovation, and global healthcare expansion accelerate market growth The global clinical microbiology market, valued at US$4.8 billion in 2023, stood at US$5.0 …
New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results
GlobeNewswire
·
August 13, 2025
SALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today released findings from its latest Cancer Risk Survey that uncover a striking contradiction in …
Center for Internet Security Selects Sophos as Premier Partner for Endpoint Security to Protect U.S. State and Local Government Organizations
GlobeNewswire
·
August 13, 2025
DALLAS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating cyberattacks, today announced it has been selected by the Center for Internet Security, Inc. (CIS) as the endpoint protection provider for …
LaunchDarkly Co‑Founder Edith Harbaugh Returns as Chief Executive Officer
GlobeNewswire
·
August 13, 2025
SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- LaunchDarkly, the comprehensive feature management platform, today announced that the company co‑founder and former CEO Edith Harbaugh has been named Chief Executive Officer, effective immediately. Harbaugh …
Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme
GlobeNewswire
·
August 13, 2025
First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel …
Artelo Biosciences Provides Business Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
SOLANA BEACH, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, …
CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study
GlobeNewswire
·
August 13, 2025
- The CTMX-2051-101 study has enrolled 73 colorectal cancer patients to-date, aligned with the Company’s goal of providing a Phase 1 data update in Q1 2026 - - The CTMX-2051-101 study remains active and patients continue to be dosed with CX-2051 across all …
Bitdeer Announces July 2025 Production and Operations Update
GlobeNewswire
·
August 13, 2025
- Increased self-mining hashrate by 35% to 22.3 EH/s on continued deployment of SEALMINERs - 159 MW energized in Bhutan and Norway; Rockdale, Texas Hydro-cooling conversion completed SINGAPORE, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group ( …
FOXO TECHNOLOGIES INC. ANNOUNCES THAT ITS COMMON STOCK CAN BE QUOTED AND TRADED ON THE OVER THE COUNTER MARKET FROM AUGUST 13, 2025.
GlobeNewswire
·
August 13, 2025
WEST PALM BEACH, FLORIDA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (“FOXO” or the “Company”) announces that it has received a letter from NYSE on August 12, 2025 confirming that NYSE Regulation has determined to commence proceedings to …
BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer
GlobeNewswire
·
August 13, 2025
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies …
ElevateBio BaseCamp Achieves ICMC™ Certification for Commercial Cell and Gene Therapy Manufacturing Capabilities
GlobeNewswire
·
August 13, 2025
ICMC certification delivered by Dark Horse Consulting certifies ElevateBio’s compliant and scalable manufacturing capabilities for advanced therapies using U.S. and E.U. commercial-level evaluation standards BaseCamp is the first genetic medicine …
PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
Positive Phase 3 SHIELD II Trial Results - D-PLEX₁₀₀ successfully met its primary efficacy endpoint and demonstrated 58% reduction in SSI NDA submission expected in Q1 2026 Unveiled a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the …
Sagimet Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 13, 2025
Denifanstat met all primary and secondary endpoints in Phase 3 clinical trial in moderate to severe acne conducted by license partner Ascletis in China Initiated first-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 being developed for acne in …
Nasus Pharma Announces Pricing of $10 Million Initial Public Offering
GlobeNewswire
·
August 13, 2025
TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions …